Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 24 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-5.49 Insider Own42.69% Shs Outstand10.62M Perf Week1.51%
Market Cap73.81M Forward P/E- EPS next Y-0.56 Insider Trans0.00% Shs Float7.00M Perf Month4.68%
Income-62.99M PEG- EPS next Q-0.93 Inst Own11.34% Short Float0.64% Perf Quarter28.24%
Sales22.40M P/S3.30 EPS this Y-31.49% Inst Trans-15.56% Short Ratio0.43 Perf Half Y27.16%
Book/sh16.32 P/B0.37 EPS next Y83.13% ROA-20.17% Short Interest0.04M Perf Year-51.01%
Cash/sh5.36 P/C1.13 EPS next 5Y- ROE-25.21% 52W Range2.85 - 14.55 Perf YTD2.20%
Dividend Est.- P/FCF- EPS past 5Y- ROI-31.48% 52W High-58.49% Beta-0.14
Dividend TTM- Quick Ratio2.03 Sales past 5Y-15.03% Gross Margin45.59% 52W Low111.93% ATR (14)0.30
Dividend Ex-DateFeb 17, 2016 Current Ratio2.10 EPS Y/Y TTM88.46% Oper. Margin-225.14% RSI (14)56.88 Volatility3.21% 4.26%
Employees324 Debt/Eq0.01 Sales Y/Y TTM-88.88% Profit Margin-281.18% Recom1.00 Target Price9.00
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q-964.34% Payout- Rel Volume0.37 Prev Close6.00
Sales Surprise3.44% EPS Surprise62.96% Sales Q/Q-63.77% EarningsJun 18 BMO Avg Volume104.59K Price6.04
SMA201.37% SMA5013.71% SMA20013.60% Trades Volume39,068 Change0.67%
Date Action Analyst Rating Change Price Target Change
Jan-18-23Initiated Cantor Fitzgerald Overweight $7
Jun-20-24 06:00AM
Jun-18-24 02:52PM
Jun-17-24 08:30AM
Apr-01-24 01:53PM
07:30AM Loading…
Feb-09-24 09:25AM
Nov-20-23 06:00AM
Nov-01-23 06:00AM
Sep-15-23 07:10AM
Aug-29-23 12:46AM
Jun-30-23 08:00AM
Jun-26-23 09:30AM
Jun-25-23 08:45PM
Jun-05-23 07:20AM
08:56AM Loading…
Mar-14-23 08:56AM
Mar-02-23 07:00AM
Feb-02-23 04:01PM
Jan-19-23 05:00AM
Jan-17-23 10:00AM
Jan-10-23 08:05AM
Dec-16-22 06:27AM
Nov-30-22 09:15AM
Nov-10-22 08:00AM
Sep-09-22 11:17AM
Aug-12-22 09:34AM
Aug-08-22 04:45AM
Jul-16-22 08:03AM
Jun-08-22 12:56PM
Jun-06-22 09:55AM
12:00PM Loading…
May-23-22 12:00PM
May-19-22 12:15PM
May-18-22 06:30PM
May-17-22 11:00AM
Prenetics Global Ltd. engages in the development of genomics-driven health sciences that seek early detection, prevention, and treatment of cancer. The firm offers products and services under the brands of CircleDNA, Insighta, and ACT Genomics. It operates through the Prevention and Diagnostics segments. The Prevention segment refers to the design and sale of genetics testing and stool-based DNA test for early colorectal cancer screening. The Diagnostic segment focuses on the sale of precision oncology testing services. The company was founded by Sheng Wu Yeung and Chi Hung Tzang in 2014 and is headquartered in Hong Kong.